CompletedNot Applicable

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

United States35 participantsStarted 2014-04

Plain-language summary

This pilot clinical trial studies the feasibility of a telephone-based educational intervention in improving communication between patients with stage 0-III cancer and their children. An educational program delivered by telephone may help parents talk with their school-age child about their cancer.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parents will be eligible if they have an initial diagnosis of non-metastatic cancer of any type (stage 0-3), including melanoma, colorectal, cervical, leukemia, lymphoma or breast cancer within the past 7 months * Read and write English among their languages of choice * Have ready access to a telephone * Have a child 5-12 years old living at home who has been told their parent's cancer diagnosis * The child is living at home and does not have learning challenges * No prior malignancy is allowed except for adequately treated basal (or squamous cell) skin cancer

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Recruitment and retention, monitored by tracking detailed recruitment spreadsheets

Timeframe: Up to 3 months

Dosage and fidelity, monitored for each intervention session using Performance Checklists

Timeframe: Up to 3 months

Acceptability of the program, assessed from interview data obtained from the Exit interview and the Swanson Caring Professional Scale

Timeframe: Up to 3 months

Rate of receipt of mailed materials both to participants and from participants

Timeframe: Up to 3 months

Duration of phone intervention sessions

Timeframe: Up to 3 months

Rate of success in scheduling and completing intervention sessions by telephone

Timeframe: Up to 3 months

Quality of data on baseline and post-intervention measures

Timeframe: Up to 3 months

Trial details

NCT IDNCT02129049

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-07

View on ClinicalTrials.gov More Breast Cancer trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Recruitment and retention, monitored by tracking detailed recruitment spreadsheets

Timeframe: Up to 3 months

Dosage and fidelity, monitored for each intervention session using Performance Checklists

Timeframe: Up to 3 months

Acceptability of the program, assessed from interview data obtained from the Exit interview and the Swanson Caring Professional Scale

Timeframe: Up to 3 months

Rate of receipt of mailed materials both to participants and from participants

Timeframe: Up to 3 months

Duration of phone intervention sessions

Timeframe: Up to 3 months

Rate of success in scheduling and completing intervention sessions by telephone

Timeframe: Up to 3 months

Quality of data on baseline and post-intervention measures

Timeframe: Up to 3 months